Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy 23andMe Holding CoClass A Common Stock (ME) stock

Learn how to easily invest in 23andMe Holding CoClass A Common Stock stock.

Genetic testing company 23andMe is going public via a special purpose acquisition company (SPAC). We'll update this page as new information becomes available.

How to buy shares in 23andMe Holding CoClass A Common Stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ME – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

23andMe Holding CoClass A Common Stock stock price (NASDAQ: ME)

Use our graph to track the performance of ME stocks over time.

23andMe Holding CoClass A Common Stock shares at a glance

Information last updated 2021-07-26.
52-week range$8.56 - $17.80
50-day moving average $10.81
200-day moving average $11.16
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy 23andMe Holding CoClass A Common Stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy 23andMe Holding CoClass A Common Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

23andMe Holding CoClass A Common Stock financials

Revenue TTM $243.9 million
Gross profit TTM $117 million
Return on assets TTM -27.02%
Return on equity TTM -97.69%
Profit margin -75.28%
Book value N/A
Market capitalisation $3.8 billion

TTM: trailing 12 months

Shorting 23andMe Holding CoClass A Common Stock shares

There are currently 6.9 million 23andMe Holding CoClass A Common Stock shares held short by investors – that's known as 23andMe Holding CoClass A Common Stock's "short interest". This figure is 19.9% up from 5.8 million last month.

There are a few different ways that this level of interest in shorting 23andMe Holding CoClass A Common Stock shares can be evaluated.

23andMe Holding CoClass A Common Stock's "short interest ratio" (SIR)

23andMe Holding CoClass A Common Stock's "short interest ratio" (SIR) is the quantity of 23andMe Holding CoClass A Common Stock shares currently shorted divided by the average quantity of 23andMe Holding CoClass A Common Stock shares traded daily (recently around 2.9 million). 23andMe Holding CoClass A Common Stock's SIR currently stands at 2.41. In other words for every 100,000 23andMe Holding CoClass A Common Stock shares traded daily on the market, roughly 2410 shares are currently held short.

To gain some more context, you can compare 23andMe Holding CoClass A Common Stock's short interest ratio against those of similar companies.

However 23andMe Holding CoClass A Common Stock's short interest can also be evaluated against the total number of 23andMe Holding CoClass A Common Stock shares, or, against the total number of tradable 23andMe Holding CoClass A Common Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 23andMe Holding CoClass A Common Stock's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 23andMe Holding CoClass A Common Stock shares in existence, roughly 10 shares are currently held short) or 0.0701% of the tradable shares (for every 100,000 tradable 23andMe Holding CoClass A Common Stock shares, roughly 70 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 23andMe Holding CoClass A Common Stock.

Find out more about how you can short 23andMe Holding CoClass A Common Stock stock.

23andMe Holding CoClass A Common Stock share dividends

We're not expecting 23andMe Holding CoClass A Common Stock to pay a dividend over the next 12 months.

23andMe Holding CoClass A Common Stock overview

23andMe Holding Co. operates as a consumer genetics and research company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No. 3) Limited to leverage genetic insights to validate, develop, and commercialize promising drugs. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development.

23andMe Holding CoClass A Common Stock in the news

There are no recent company news

Frequently asked questions

What percentage of 23andMe Holding CoClass A Common Stock is owned by insiders or institutions?
Currently 3.634% of 23andMe Holding CoClass A Common Stock shares are held by insiders and 17.243% by institutions.
When does the fiscal year end for 23andMe Holding CoClass A Common Stock?
23andMe Holding CoClass A Common Stock's fiscal year ends in March.
Where is 23andMe Holding CoClass A Common Stock based?
23andMe Holding CoClass A Common Stock's address is: 223 North Mathilda Avenue, Sunnyvale, CA, United States, 94086

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site